全球人工水晶体（IOL）市场 - 市场规模（依细分市场）、占有率、监管、偿付、治疗、预测（~2033年）

视力障碍严重影响成年人的生活品质。有视力障碍的成年人的劳动参与度和生产力往往较低。对于老年人来说，视力丧失可能导致社会孤立、行走困难、跌倒和骨折的风险增加，以及提前入住疗养院或辅助生活设施的可能性增加。随着人口的成长和老化，预计会有更多的人出现视力障碍的风险增加。视力恢復和復健对于改善因白内障、糖尿病视网膜病变、青光眼、外伤后遗症、老年黄斑部病变等眼部疾病引起的不可逆视力丧失的人的功能非常有效。

本报告研究和分析了全球人工水晶体（IOL）市场，提供了有关主要参与者和市场占有率、主要趋势、创新产品和技术以及竞争格局的资讯。

市场模型的主要内容如下。

已上市的人工水晶体（IOL）和不断变化的竞争格局

• 对主要产业趋势的考察
• 人工水晶体（IOL）市场年收入和市场前景（依细分市场）（2015-2033年）
• 依细分市场划分的手术总数、单位数量、平均售价和市场价值的详细资料

全球、区域和国家层面的特定市场考察

• 依地区细分全球趋势的特定市场定性资讯和国家考察
• 人工水晶体（IOL）市场的 SWOT 分析
• 人工水晶体（IOL）市场竞争动态的考察与趋势

掌握包括医疗保健系统概述真实情况，促进市场了解。市场进入部分还提供有关偿付政策和监管环境的讯息，能够更深入地研究市场动态。

• 各国医疗保健系统概览
• 依国家/地区划分的偿付政策
• 各国医疗科技监理状况

目标公司

• Alcon Inc
• Johnson & Johnson Vision Care Inc
• Hoya Corp
• Carl Zeiss Meditec AG
• Bausch and Lomb Inc
• STAAR Surgical Company
• 其他

Intraocular Lens (IOL) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Ophthalmic Devices therapeutic area.

Intraocular Lens is an artificial lens made of plastic, silicone, acrylic or other material that is implanted inside the eye during cataract surgery.

Vision impairment severely impacts quality of life among adult populations. Adults with vision impairment often have lower rates of workforce participation and productivity. In the case of older adults, vision impairment can contribute to social isolation, difficulty walking, a higher risk of falls and fractures, and a greater likelihood of early entry into nursing or care homes. Population growth and ageing are expected to increase the risk that more people acquire vision impairment. Vision restoration and rehabilitation is very effective in improving functioning for people with an irreversible vision impairment that can be caused by eye conditions such as cataracts, diabetic retinopathy, glaucoma, consequences of trauma and age-related macular degeneration.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Intraocular Lens (IOL) and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Intraocular Lens (IOL) market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Intraocular Lens (IOL) market.
• Competitive dynamics insights and trends provided for Intraocular Lens (IOL) market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Alcon Inc, Johnson & Johnson Vision Care Inc, Hoya Corp, Carl Zeiss Meditec AG, Bausch and Lomb Inc, STAAR Surgical Company, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Intraocular Lens (IOL) marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Intraocular Lens (IOL) market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Intraocular Lens (IOL) market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Intraocular Lens (IOL) market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.